Acute idiopathic blind spot enlargement syndrome (AIBSES) with retinal vasculitis.
AIBSES
Blind spot
Blind spot enlargement
Retinal vasculitis
Journal
American journal of ophthalmology case reports
ISSN: 2451-9936
Titre abrégé: Am J Ophthalmol Case Rep
Pays: United States
ID NLM: 101679941
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
02
06
2022
revised:
05
11
2022
accepted:
19
11
2022
entrez:
23
12
2022
pubmed:
24
12
2022
medline:
24
12
2022
Statut:
epublish
Résumé
To report the clinical and anatomical features of an unusual case of acute idiopathic blind spot enlargement syndrome (AIBSES) with retinal vasculitis. A 39-year-old patient, who was a known case of chronic headache with nonspecific visual symptoms for nine years, developed scotomas in her right eye. She was initially diagnosed with AIBSES which had been stable, but later worsened with symptoms of subsequent blind spot enlargement and photopsia on the left eye a year later. Increase in the size of the blind spot over the left eye and stability of the blind spot enlargement over the right eye was documented on Humphrey visual field (HVF) testing. Due to the rapid onset and severity of symptoms, an inflammatory etiology was entertained and this prompted referral to our clinic. At initial presentation, fluorescein angiogram (FA) revealed moderate diffuse vasculitis and disc leakage in the left eye, which existed alongside the enlarged blind spot. Corticosteroid treatment was suggested and initiated. The patient was found to have a reduction in the size of her blind spot and a decrease in severity of retinal vasculitis a month later. Unfortunately, the patient was then lost to follow up and had stopped steroid treatment of her own accord. After nine months without treatment, the patient's blind spot increased to a larger size than her initial presentation, as documented on HVF, with recurrence of vasculitis in the left eye. This is an unusual case of AIBSES which presented with vasculitis and rapid progression and has responded to steroids. Though monocular AIBSES has been shown to later affect the contralateral eye, concurrent vasculitis with AIBSES has not previously been reported. Furthermore, the response to treatment with reduction in blind spot enlargement is unusual for AIBSES. These findings stress the need for regular monitoring in cases of AIBSES.
Identifiants
pubmed: 36561880
doi: 10.1016/j.ajoc.2022.101760
pii: S2451-9936(22)00506-0
pmc: PMC9763352
doi:
Types de publication
Case Reports
Langues
eng
Pagination
101760Informations de copyright
© 2022 The Authors.
Déclaration de conflit d'intérêts
The authors declare that there are no conflicts of interest related to this article.
Références
Retina. 1995;15(5):373-8
pubmed: 8594628
Eye Sci. 2014 Sep;29(3):143-50
pubmed: 26011969
Int Ophthalmol. 2018 Apr;38(2):815-821
pubmed: 28374276
Arch Ophthalmol. 2001 Jan;119(1):59-63
pubmed: 11146727
Am J Ophthalmol Case Rep. 2022 May 02;26:101558
pubmed: 35572613
Arch Ophthalmol. 1988 Jan;106(1):44-9
pubmed: 3337705
Am J Ophthalmol. 2002 Sep;134(3):329-39
pubmed: 12208243
Arch Soc Esp Oftalmol. 2013 Nov;88(11):450-2
pubmed: 24157324
Am J Ophthalmol Case Rep. 2016 Mar 11;1:13-15
pubmed: 29503882
Ocul Immunol Inflamm. 2014 Dec;22(6):494-6
pubmed: 25393756
Arch Ophthalmol. 1991 Oct;109(10):1403-7
pubmed: 1929929
Ophthalmology. 2002 Jul;109(7):1326-35
pubmed: 12093658
Case Rep Ophthalmol. 2011 Apr 01;2(1):116-22
pubmed: 21503168